MarketResearchNest.com adds “Global Coronary Artery Bypass Grafts (CABG) Market 2017-2021” new reports to its research database. The report spread across 93 pages with tables and figures in it.
The analysts forecast the global coronary artery bypass grafts (CABG) market to grow at a CAGR of 5.83% during the period 2017-2021. CABG is a surgical procedure performed to improve blood flow to the heart. It is used for patients suffering with a severe coronary heart disease (CHD). CHD is a disease that leads to deposition of plaque inside arteries and disrupts the flow of oxygen to the heart. During the CABG procedure, a healthy artery or vein from the body is connected or grafted to the blocked coronary artery to create a new path for oxygen-rich blood to flow to the heart muscle.
Get more details about report at https://www.marketresearchnest.com/global-coronary-artery-bypass-grafts-cabg-market-2017-2021.html .
Researcher recognizes the following companies as the key players in the global coronary artery bypass grafts (CABG) market: Abbott, MAQUET, Medtronic, and Terumo Medical.
Other Prominent Vendors in the market are: Boston Scientific, Dextera Surgical, Edwards Lifesciences, Ethicon (a subsidiary of Johnson & Johnson), Genesee BioMedical, Hancock Jaffe Laboratories, HeartWare, KARL STORZ, LivaNova, Neograft, NOVADAQ, Teleflex, VASOPREP SURGICAL, and Vitalitec
Commenting on the report, an analyst team said: “One trend in the market is rise in medical tourism. Developing nations are slowly transforming into a hub for medical tourism. They are providing medical care at a much lower cost when compared with the developed nations. The improving medical infrastructure in developing nations has boosted the growth of medical tourism.”
Order a Purchase Report Copy at https://www.marketresearchnest.com/purchase.php?reportid=279631 .
According to the report, one driver in the market is favorable reimbursement policies. Well-structured reimbursement policies for medical devices have been under consideration by insurance regulatory firms for some time now. These policies are quite favorable for patients in some countries. The change in reimbursement policies will drive the sales of CABG. In APAC, many countries such as Thailand, India, China, and Singapore have increased their GDP spending on public healthcare. With an increased spending on healthcare, the CABG market will grow significantly in the region.
Further, the report states that one challenge in the market is availability of alternate treatments. Primary causes of PVDs are smoking, high blood pressure, diabetes, and high cholesterol. These factors are all mainly related to lifestyle changes. Changes to lifestyle and adoption of healthy habits lead to lowering of lifestyle-related diseases. In some cases, medication can also be used to treat CHDs. For instance, antiplatelet, statins, and beta-blockers and nitrates are used to treat CHDs. Less risky procedures such as balloon angioplasty can be used to treat an affected blood vessel by filling it with air to clear a blockage. Stents are also used to treat clogged arteries. Stents are inserted into the affected area to keep an artery from becoming clogged again.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Inquire before buying at https://www.marketresearchnest.com/enquirybuy.php?reportid=279631 .
MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.
Mr. Jeet Jain
+1-240-284-8070 / +44-20-3290-4151